Trial NCT04238390

View at ClinicalTrials.gov 
Org. Study IDs: UQCCR-DP-AS-2019-001

Last trial update was posted on 2022-05-19

MeSH Interventions

Ceftolozane Ceftolozane, tazobactam drug combination Meropenem Tazobactam

MeSH Conditions

Bacteremia Sepsis

Other Conditions

Bacteremia Caused by Gram-Negative Bacteria

Stopping Reasons

The decision to withdraw the study was made due to delayed logistics of the supply chain of ceftolozane-tazobactam along with the immense complexities of conducting clinical research felt because of the COVID-19 pandemic.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID